Healthcare Global Enterprises Ltd
HCGHealthcare Global Enterprises Ltd
HCG
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 101.25 | 6.13 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 49.93 | 6.39 | 0.52% |
Forecast & Ratings
Detailed Forecast from 9 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Healthcare Global Enterprises Limited is a specialty healthcare provider. The Company is focused on cancer and fertility.
Peers
Compare with peersApollo Hospitals Enterprise Ltd
Max Healthcare Institute Ltd
Fortis Healthcare Ltd
Global Health Ltd
Dr. Lal PathLabs Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 588.16 | 709.78 | 861.91 | 986.09 | 1,102.61 | 1,036.17 | 1,560.36 | 1,707.63 | 1,933.35 | 2,004.31 | ||||||||||
Raw Materials | 149.13 | 175.92 | 196.64 | 221.49 | 236.35 | 238.17 | 360.98 | 432.38 | 1,582.53 | 1,630.86 | ||||||||||
| Power & Fuel Cost | 14.35 | 16.42 | 22.89 | 28.82 | 33.26 | 31.75 | 34.54 | 36.89 | ||||||||||||
| Employee Cost | 100.53 | 121.93 | 157.71 | 184.52 | 208.03 | 195.94 | 233.65 | 275.12 | ||||||||||||
| Selling & Administrative Expenses | 64.50 | 83.00 | 285.43 | 362.38 | 367.58 | 333.50 | 430.81 | 526.94 | ||||||||||||
| Operating & Other expenses | 176.97 | 197.85 | 58.25 | 67.25 | 90.56 | 187.09 | 156.57 | 124.46 | ||||||||||||
EBITDA | 82.68 | 114.66 | 140.99 | 121.63 | 166.83 | 49.72 | 343.81 | 311.84 | 350.82 | 373.45 | ||||||||||
| Depreciation/Amortization | 44.08 | 56.83 | 71.46 | 85.09 | 148.45 | 159.22 | 158.28 | 163.47 | 174.36 | 180.36 | ||||||||||
| PBIT | 38.60 | 57.83 | 69.53 | 36.54 | 18.38 | -109.50 | 185.53 | 148.37 | 176.46 | 193.09 | ||||||||||
| Interest & Other Items | 38.33 | 23.00 | 42.35 | 69.91 | 137.65 | 119.17 | 97.77 | 103.50 | 108.74 | 116.90 | ||||||||||
| PBT | 0.27 | 34.83 | 27.18 | -33.37 | -119.27 | -228.67 | 87.76 | 44.87 | 67.72 | 76.19 | ||||||||||
| Taxes & Other Items | 1.73 | 12.67 | 6.65 | -8.58 | -12.57 | -35.20 | 34.04 | 15.53 | 19.58 | 23.58 | ||||||||||
| Net Income | -1.46 | 22.16 | 20.53 | -24.79 | -106.70 | -193.47 | 53.72 | 29.34 | 48.14 | 52.61 | ||||||||||
| EPS | -0.19 | 2.60 | 2.38 | -2.84 | -12.08 | -18.08 | 4.06 | 2.11 | 3.46 | 3.78 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFInvestor Presentation
Peers & Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Healthcare Global Enterprises Ltd | 110.65 | 6.13 | — |
| Apollo Hospitals Enterprise Ltd | 109.72 | 13.47 | 0.23% |
| Max Healthcare Institute Ltd | 79.63 | 10.02 | 0.17% |
| Fortis Healthcare Ltd | 67.92 | 4.75 | 0.19% |
Price Comparison
Compare HCG with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Decreased Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has decreased by 2.79%
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
Mutual Funds Holding Trend
Increased Mutual Fund Holding
In last 3 months, mutual fund holding of the company has increased by 2.24%
Top 5 Mutual Funds holding Healthcare Global Enterprises Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Tata Small Cap Fund-Direct Plan-Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.2194% | Percentage of the fund’s portfolio invested in the stock 1.40% | Change in the portfolio weight of the stock over the last 3 months -0.36% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 32/54 (-3) |
Nippon India ELSS Tax Saver Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.1683% | Percentage of the fund’s portfolio invested in the stock 0.73% | Change in the portfolio weight of the stock over the last 3 months 0.26% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 56/67 (+3) |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Plan Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.8376% | Percentage of the fund’s portfolio invested in the stock 2.37% | Change in the portfolio weight of the stock over the last 3 months 0.90% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 12/49 (+3) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
HCG has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNet profit of Healthcare Global Enterprises rose 58.74% to Rs 12.08 crore in the quarter ended June 2024 as against Rs 7.61 crore during the previous quarter ended June 2023. Sales rose 14.14% to Rs 524.69 crore in the quarter ended June 2024 as against Rs 459.71 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales524.69459.71 14 OPM %17.3216.16 - PBDT66.0051.53 28 PBT18.9910.52 81 NP12.087.61 59 Powered by Capital Market - Live
Broker’s call: HealthCare Global (Add)
HealthCare Global Enterprises acquires Andhra-based MGCHRI for Rs 414 cr
CVC Mulls Sale of Controlling Stake In Indian Hospital Chain HealthCare Global
Corporate hospitals to see 8-10 pc revenue growth in FY24: Report
Buy HealthCare Global Enterprises; target of Rs 375: Prabhudas Lilladher
Buy HealthCare Global Enterprises; target of Rs 375: Prabhudas Lilladher
Fundamental Radar: This multibagger stock looks set to hit fresh 52-week highs in 2023; here’s why
Buy HealthCare Global Enterprises; target of Rs 375: Prabhudas Lilladher
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 14.41%, vs industry avg of 10.16%
Increasing Market Share
Over the last 5 years, market share increased from 2.68% to 3.13%